Increased miR-132 level is associated with visual memory dysfunction in patients with depression

Neuropsychiatric Disease and Treatment

Volumn 12, Issue , 2016, Pages 2905-2911

  Liu, Ye ^a,b   Yang, Xiao ^a,b   Zhao, Liansheng ^a,b   Zhang, Jian ^a,b   Li, Tao ^a,b   Ma, Xiaohong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

CANTAB; Cognition; Major depressive disorder; Memory; miR 132

Indexed keywords

MICRORNA 132;

ADULT; AGE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; GENE EXPRESSION; HAMILTON ANXIETY SCALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; PATTERN RECOGNITION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SYMPTOMATOLOGY; UPREGULATION; VISUAL MEMORY;

EID: 84995596041     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S116287     Document Type: Article

References (53)

1. Airaksinen E, Larsson M, Lundberg I, Forsell Y. Cognitive functions in depressive disorders: evidence from a population-based study. Psychol Med. 2004;34(1): 83-91.
2. Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156(7): 1000-1006.
3. Austin M-P, Mitchell P, Goodwin GM. Cognitive deficits in depression possible implications for functional neuropathology. Br J Psychiatry. 2001;178(3): 200-206.
4. Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lönnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord. 2008;106(1): 1-27.
5. Griffiths S, Scott H, Glover C, et al. Expression of long-term depression underlies visual recognition memory. Neuron. 2008;58(2): 186-194.
6. OP, Waterreus A, Spry N, Flicker L, Martins RN. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004;29(8): 1071-1081.
7. Hickie I, Naismith S, Ward PB, et al. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry. 2005;186: 197-202.
8. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007;8(4): 253-262.
9. Cortijo S, Wardenaar R, Colomé-Tatché M, et al. Mapping the epigenetic basis of complex traits. Science. 2014;343(6175): 1145-1148.
10. Mill J, Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol Psychiatry. 2007;12(9): 799-814.
11. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011;12(2): 99-110.
12. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2): 215-233.
13. Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell. 2008;132(1): 9-14.
14. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39(Database issue): D152-D157.
15. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9): 597.
16. Konopka W, Kiryk A, Novak M, et al. MicroRNA loss enhances learning and memory in mice. J Neurosci. 2010;30(44): 14835-14842.
17. Gardiner E, Beveridge NJ, Wu JQ, et al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Mol Psychiatry. 2012;17(8): 827-840.
18. Katsuura S, Kuwano Y, Yamagishi N, et al. MicroRNAs miR-144/144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students. Neurosci Lett. 2012;516(1): 79-84.
19. Lai CY, Yu SL, Hsieh MH, et al. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One. 2011;6(6): e21635.
20. Rong H, Liu TB, Yang KJ, et al. MicroRNA-134 plasma levels before and after treatment for bipolar mania. J Psychiatr Res. 2011;45(1): 92-95.
21. Hébert SS, Papadopoulou AS, Smith P, et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet. 2010;19(20): 3959-3969.
22. Lee S-T, Chu K, Im W-S, et al. Altered microRNA regulation in Huntington’s disease models. Exp Neurol. 2011;227(1): 172-179.
23. Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ. A microRNA-based gene dysregulation pathway in Huntington’s disease. Neurobiol Dis. 2008;29(3): 438-445.
24. Hollander JA, Im H-I, Amelio AL, et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature. 2010;466(7303): 197-202.
25. Mouillet-Richard S, Baudry A, Launay J-M, Kellermann O. MicroRNAs and depression. Neurobiol Dis. 2012;46(2): 272-278.
26. Alvarez-Saavedra M, Antoun G, Yanagiya A, et al. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum Mol Genet. 2010;20(4): 731-751.
27. Vo N, Klein ME, Varlamova O, et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A. 2005;102(45): 16426-16431.
28. Impey S, Davare M, Lasiek A, et al. An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Mol Cell Neurosci. 2010;43(1): 146-156.
29. Hansen KF, Sakamoto K, Wayman GA, Impey S, Obrietan K. Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory. PLoS One. 2010;5(11): e15497.
30. Edbauer D, Neilson JR, Foster KA, et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron. 2010;65(3): 373-384.
31. First MB, Spitzer RL, Gibbon M, Williams JB. User’s Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version. Washington, DC: American Psychiatric Pub; 1997.
32. APA. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: APA; 2003.
33. Shang C, Gau S. Visual memory as a potential cognitive endophenotype of attention deficit hyperactivity disorder. Psychol Med. 2011;41(12): 2603-2614.
34. Barrett SL, Mulholland CC, Cooper SJ, Rushe TM. Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia. Br J Psychiatry. 2009;195(1): 67-72.
35. Sahakian BJ, Morris RG, Evenden JL, et al. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson’s disease. Brain. 1988;111(3): 695-718.
36. Campbell S, MacQueen G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci. 2004;29(6): 417.
37. Vythilingam M, Vermetten E, Anderson GM, et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry. 2004;56(2): 101-112.
38. Landrø NI, Stiles TC, Sletvold H. Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(4): 233-240.
39. Reischies FM, Neu P. Comorbidity of mild cognitive disorder and depression-a neuropsychological analysis. Eur Arch Psychiatry Clin Neurosci. 2000;250(4): 186-193.
40. Naismith SL, Hickie IB, Turner K, et al. Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. J Clin Exp Neuropsychol. 2003;25(6): 866-877.
41. Porter RJ, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry. 2003;182(3): 214-220.
42. Wanet A, Tacheny A, Arnould T, Renard P. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res. 2012;40(11): 4742-4753.
43. Luikart BW, Perederiy JV, Westbrook GL. Dentate gyrus neurogenesis, integration and microRNAs. Behav Brain Res. 2012;227(2): 348-355.
44. Numakawa T, Yamamoto N, Chiba S, et al. Growth factors stimulate expression of neuronal and glial miR-132. Neurosci Lett. 2011;505(3): 242-247.
45. Su M, Hong J, Zhao Y, Liu S, Xue X. MeCP2 controls hippocampal brain-derived neurotrophic factor expression via homeostatic interactions with microRNA-132 in rats with depression. Mol Med Rep. 2015;12(4): 5399-5406.
46. Scott HL, Tamagnini F, Narduzzo KE, et al. MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci. 2012;36(7): 2941-2948.
47. Bredy TW, Lin Q, Wei W, Baker-Andresen D, Mattick JS. MicroRNA regulation of neural plasticity and memory. Neurobiol Learn Mem. 2011;96(1): 89-94.
48. Burt DB, Zembar MJ, Niederehe G. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull. 1995;117(2): 285.
49. Veiel HO. A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol. 1997;19(4): 587-603.
50. Eysenck MW, Calvo MG. Anxiety and performance: the processing efficiency theory. Cogn Emot. 1992;6(6): 409-434.
51. Kessler RC, Nelson CB, McGonagle KA, Liu J. Comorbidity of DSM-III - R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry. 1996;(30): 17-30.
52. Zajecka JM, Ross JS. Management of comorbid anxiety and depression. J Clin Psychiatry. 1995;56(suppl 2): 10-13.
53. Kizilbash AH, Vanderploeg RD, Curtiss G. The effects of depression and anxiety on memory performance. Arch Clin Neuropsychol. 2002;17(1): 57-67.